Integrated specialty pharmacy yields high PCSK9 inhibitor access and initiation rates VW Reynolds, ME Chinn, JA Jolly, TN Kelley, ME Peter, L Choi, S Nwosu, ... Journal of Clinical Lipidology 13 (2), 254-264, 2019 | 36 | 2019 |
Adherence to disease-modifying therapies at a multiple sclerosis clinic: the role of the specialty pharmacist AM Banks, ME Peter, GM Holder, JA Jolly, BM Markley, SL Zuckerman, ... Journal of Pharmacy Practice 33 (5), 605-611, 2020 | 29 | 2020 |
“You need to be a good listener”: recruiters’ use of relational communication behaviors to enhance clinical trial and research study accrual SE Morgan, A Occa, JN Potter, A Mouton, ME Peter Journal of health communication 22 (2), 95-101, 2017 | 27 | 2017 |
Access to hepatitis C direct-acting antiviral therapy in hepatitis C-positive donor to hepatitis C-negative recipient solid-organ transplantation in a real-world setting C Edmonds, A Carver, J DeClercq, L Choi, M Peter, K Schlendorf, R Perri, ... The American Journal of Surgery 223 (5), 975-982, 2022 | 17 | 2022 |
Adherence and persistence in patients with rheumatoid arthritis at an integrated health system specialty pharmacy ME Peter, AD Zuckerman, J DeClercq, L Choi, C James, K Cooper, J Choi, ... Journal of Managed Care & Specialty Pharmacy 27 (7), 882-890, 2021 | 15 | 2021 |
Rheumatoid arthritis medication adherence in a health system specialty pharmacy. N Berger, M Peter, J DeClercq, L Choi, AD Zuckerman The American journal of managed care 26 (12), e380-e387, 2020 | 15 | 2020 |
Comparison of provider satisfaction with specialty pharmacy services in integrated health-system and external practice models: a multisite survey RH Anguiano, AD Zuckerman, E Hall, E Diamantides, L Kumor, ... American Journal of Health-System Pharmacy 78 (11), 962-971, 2021 | 13 | 2021 |
Assessing the impact of limited distribution drug networks based on time to accessing oral oncolytic agents at an integrated specialty pharmacy M Jagasia | 13 | 2020 |
Pharmacist interventions to improve specialty medication adherence: study protocol for a randomized controlled trial AM Kibbons, M Peter, J DeClercq, L Choi, J Bell, J Jolly, E Cherry, ... Drugs-real world outcomes 7, 295-305, 2020 | 9 | 2020 |
Development of quality measures for use of self-injectable biologic therapy in inflammatory bowel disease: an integrated specialty pharmacy initiative NB Shah, JA Jolly, SN Horst, M Peter, H Limper, AD Zuckerman American Journal of Health-System Pharmacy 76 (17), 1296-1304, 2019 | 8 | 2019 |
Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy ME Peter, B Markley, J DeClercq, L Choi, G Givens, AD Zuckerman, ... Journal of Managed Care & Specialty Pharmacy 27 (2), 256-262, 2021 | 6 | 2021 |
Primary medication nonadherence to oral oncology specialty medications AD Zuckerman, NB Shah, K Perciavalle, B Looney, ME Peter, J DeClercq, ... Journal of the American Pharmacists Association 62 (3), 809-816. e1, 2022 | 5 | 2022 |
An opportunity to address modifiable breast cancer risks: mammography screening and physical activity readiness to change MD Thomson, ME Peter Preventive medicine reports 5, 41-44, 2017 | 5 | 2017 |
Primary medication nonadherence calculation method specifications impact resulting rates AD Zuckerman, J DeClercq, NB Shah, VW Reynolds, ME Peter, AM Pavlik, ... Research in Social and Administrative Pharmacy 18 (3), 2478-2483, 2022 | 4 | 2022 |
Integrating pharmacists into a kidney transplant clinic: Developing and implementing a collaborative pharmacy practice agreement KE Rodriguez, RJ Chelewski, ME Peter, AD Zuckerman, L Choi, ... Journal of the American Pharmacists Association 62 (1), 349-356, 2022 | 4 | 2022 |
289-OR: Automated insulin delivery use among 12,065 T1D exchange registry participants J Liu, K Miller, C Kelly, KSM Chapman, M Peter, D Finan, H Nguyen, ... Diabetes 71 (Supplement_1), 2022 | 3 | 2022 |
Exploring healthcare providers’ experiences with specialty medication and limited distribution networks ME Peter, AD Zuckerman, E Cherry, DG Schlundt, K Bonnet, N Shah, ... Plos one 17 (8), e0273040, 2022 | 2 | 2022 |
629-P: unique associations between health insurance and HbA1c in adults with type 1 diabetes C Kelly, H Nguyen, J Liu, KSM Chapman, M Peter, C Leon, K Laferriere, ... Diabetes 71 (Supplement_1), 2022 | 2 | 2022 |
Development, implementation, and evaluation of a health outcomes and research program at an integrated health-system specialty pharmacy AD Zuckerman, NB Shah, ME Peter, JA Jolly, TN Kelley American Journal of Health-System Pharmacy 78 (11), 972-981, 2021 | 2 | 2021 |
Access to direct acting antiviral therapy for recipients of solid organs from hepatitis C viremic donors C Edmonds, A Carver, J DeClercq, L Choi, M Peter, R Forbes, ... AMERICAN JOURNAL OF TRANSPLANTATION 20, 580-580, 2020 | 1 | 2020 |